Search

Your search keyword '"Diabetes therapy -- Reports -- Forecasts and trends"' showing total 482 results

Search Constraints

Start Over You searched for: Descriptor "Diabetes therapy -- Reports -- Forecasts and trends" Remove constraint Descriptor: "Diabetes therapy -- Reports -- Forecasts and trends"
482 results on '"Diabetes therapy -- Reports -- Forecasts and trends"'

Search Results

51. Diabetes Management Apps Market to Record an Exponential CAGR of 24.4% by 2031 - Exclusive Report by InsightAce Analytic

52. Non-Oncology Biologics and Biosimilars Market is Booming and Expected to Grow at a CAGR of 21.8% to 2031

53. Global and Country Cell Therapies for Type 1 Diabetes Research Report 2023: Epidemiology, Pipeline and Target Market Assessment Analysis and Forecast to 2030

54. Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompe Farmaceutici

55. Continuous Glucose Monitoring Systems Industry Projected to Reach US$ 103.5 Billion by 2033 | Future Market Insights, Inc

56. Research and Markets Releases Report: Global Diabetes Diagnostics Market

57. Research and Markets Adds Report: Digital Pharmacy Market

58. Diabetic Neuropathy Market to Hit USD 10.23 Billion by 2030 With a Growing Healthy CAGR of 8.7% | Research by SNS Insider

59. Insulin Pumps Segment Projected to Lead Growth in Global Insulin Delivery Devices Market to 2028, with a CAGR of 8.5% by 2028

60. DNA and Gene Cloning Services Market likely to surpass USD 9 billion, expected to expand at a 13.7% CAGR from 2022 to 2031: TMR Report

61. Diabetic Foot Ulcer Treatment Market to Exceed USD 11.6 Bn by 2031 with CAGR of 5.8%: TMR Study

62. Pharmaceutical Drug Delivery Market to Reach $2,307.27 Billion, Globally, by 2032 at 4.4% CAGR: Allied Market Research

63. Harnessing Technology to Enhance Diabetes Adherence: Matching the technology to the patient

64. Research and Markets Offers Report: Global Glucagon-like Peptide 1 (GLP-1) Market

65. Research and Markets Releases Report: Diabetic Food Market

66. Research and Markets Offers Report: Diabetic Food Market

67. Research and Markets Adds Report: Diabetic Food Market

68. Type 2 Diabetes Market to Accelerate Substantially During the Forecast Period (2023-2032) - DelveInsight | Key Companies - AbbVie, ACADIA, Adocia, Astellas, AstraZeneca, Cytogel, Halozyme, IItoo

69. The Global Continuous Glucose Monitoring Devices Market is Projected to reach USD 11.2 billion by 2030, with a CAGR of 4.4% from 2023 to 2030

70. Type 2 Diabetes Market to Grow Rapidly, Predicts DelveInsight | Key Companies Active in the Domain - Eli Lilly and Company, Regor, AstraZeneca, Eccogene, Pfizer, Novo Nordisk, Novartis, Amgen, MediciNova

71. United Kingdom Diabetes Market Forecast Report 2023-2028: Government Initiatives will Benefit the Market as 1 in 14 have Diabetes in the UK

72. Global Continuous Glucose Monitoring (CGM) Solutions Markets Report 2023-2027: Opportunities in Type 2 Diabetic and Non Diabetic Patients Treatment Boost Future Growth Potential

73. Global Continuous Glucose Monitoring (CGM) Solutions Markets Report 2023-2027: Technological Advancements and Strategic Partnerships Create New Opportunities for Vendors

74. Global Continuous Glucose Monitoring (CGM) Solutions Markets Report 2023-2027: Opportunities in Type 2 Diabetic and Non Diabetic Patients Treatment Boost Future Growth Potential

75. Peptide and Anticoagulant Drugs Market Exclusive Report On the Latest Trends and Future Growth to 2031 | InsightAce

76. Peptide and Anticoagulant Drugs Market - Exclusive Report On the Latest Trends and Future Growth to 2031 | InsightAce

77. Diabetes Market to Witness Growth by 2032, Estimates DelveInsight | Nano Precision Medical, Enthera, Pfizer, Scohia Pharma, Carmot Therapeutics, ImCyse, REMD Biotherapeutics, Genexine, Eli Lilly

78. Hospital-At-Home Market Worth USD 514.08 Bn to 2031 with CAGR of 8.62% | Reveals Recent InsightAce Study

79. Glucose Elevating Agents Market to Register a Steady Revenue CAGR of 6.3% by 2031 | Growth Plus Reports

80. 6 Trends to Watch in Point-of-Care IVD, according to Kalorama Information

81. 6 Trends to Watch in Point-of-Care IVD, according to Kalorama Information

82. Diabetes Devices Market to Reach Over USD 90.2 Bn by 2031 with 6.0% of CAGR | TMR Study

83. 100+ Active Companies working to develop 100+ Pipeline Therapies for Type 2 Diabetes Treatment Landscape | Major Companies - Hanmi Pharmaceuticals, Sanofi, AstraZeneca, and others

84. Global Insulin Pump Market Outlook and Forecasts Report 2023: A $6+ Billion Market by 2028 - Technological Advancements Are Revolutionizing the Insulin Delivery

85. Haemoglobin A1c Testing Devices Market Size [2023-2030] | Share, Growth, Regional Insights, Analysis Report

86. Insulin Delivery Devices Demand Fueled by Emergence of 'Smart' Pens & Needles, Market to Outstrip US$ 33.1 Billion by 2033

87. The global insulin pump market size is expected to grow at a CAGR of 8.46% 2022-2028

88. Canada Diabetes Industry Report to 2028: Featuring Medtronic, Insulet, LifeScan and Abbott Laboratories Among Others - ResearchAndMarkets.com

89. Canada Diabetes Industry Report to 2028: Featuring Medtronic, Insulet, LifeScan and Abbott Laboratories Among Others

90. Insulin Resistance Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market

91. The Diabetes Market in the Netherlands is Expected to Reach $3.36 Billion in 2028

92. The Diabetes Market in the Netherlands is Expected to Reach $3.36 Billion in 2028

93. Global Continuous Glucose Monitoring Market 2023 to 2027: Featuring B. Braun, Dexcom, F. Hoffmann La Roche and General Electric Among Others

94. Regenerative Medicine Market Growth Report ($37.48 Bn) Lead by Increasing Adoption of Gene Therapies | The Insight Partners

95. Pet Diabetes Care Devices Market to cross USD 4.5 billion by 2032, says Global Market Insights Inc

96. Type 2 Diabetes Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

97. Diabetes Clinical Trial Analysis Report 2023: Featuring 200+ Key Companies by DelveInsight

98. Availability of Improved Treatment Resources Favors the Diabetic Retinopathy Market Growth to Record a 5.8% CAGR through 2032 -- Future Market Insights, Inc

99. Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% - ResearchAndMarkets.com

100. Apheresis Equipment Market expected to reach $6.1 Billion by 2030: Grand View Research, Inc

Catalog

Books, media, physical & digital resources